Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease.
about
Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and CanadaCurrent and emerging drug treatment options for Alzheimer's disease: a systematic review.A prospective non-interventional study for evaluation of quality of life in patients with Alzheimer's disease treated with rivastigmine transdermal patch.Alzheimer's Disease: Differences of Transdermal versus Oral Treatment on Caregiving Time.Drug delivery strategies for Alzheimer's disease treatment.Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before.Rivastigmine from capsules to patch: therapeutic advances in the management of Alzheimer's disease and Parkinson's disease dementia.Skin reactions at the application site of rivastigmine patch (4.6 mg/24 h, 9.5 mg/24 h or 13.3 mg/24 h): a qualitative analysis of clinical studies in patients with Alzheimer's disease.Preparation and Characterization of Rivastigmine Transdermal Patch Based on Chitosan Microparticles.Safety and tolerability of rivastigmine transdermal patch formulation in newly diagnosed patients with Alzheimer's dementia in naturalistic conditions.Medication adherence survey of drugs useful in prevention of dementia of Alzheimer's type among Indian patients.Transdermal is better than oral: observational research of the satisfaction of caregivers of patients with Alzheimer's disease treated with rivastigmine.
P2860
Q28551402-4AD168CC-356A-434A-8586-776D07CF8D29Q34222721-DA5ADD70-D88C-489F-A556-4A96B6605532Q36372148-6EB0B791-0DB2-47F6-B983-AFD4D6F2AC72Q36467267-0E29AE40-1D55-4CBF-B8E7-4DC803E566CAQ37851509-6A961EC4-3E70-4C8E-A87D-2A1D54CCC149Q37910243-B50F2CD1-6AA6-4AAD-9D2F-DD3A35AB5288Q38350602-D625B4CA-6A01-496E-A07E-0B93AD626AA1Q41432940-C53881CC-8659-4710-AE4C-8EA01109E8F0Q42355123-7CFA714A-CF02-44EA-A921-52F42BF841F3Q42668931-6C3EB485-9CB6-4491-B1EA-65557BD33E39Q43622264-DB53AD11-AFEE-48E7-85D2-25565150A49DQ45803280-74904257-9C53-4F55-A92F-2CD321EF5059
P2860
Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease.
@en
Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease.
@nl
type
label
Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease.
@en
Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease.
@nl
prefLabel
Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease.
@en
Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease.
@nl
P2093
P2860
P50
P1476
Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease.
@en
P2093
Andreas Monsch
Edward Dziadulewicz
Hans Förstl
Hugo Daniëls
James Lindesay
Luis Cunha
Lutz Frölich
Murat Emre
Oleg Levin
Pablo Martínez-Lage
P2860
P304
P356
10.1111/J.1755-5949.2010.00141.X
P577
2010-04-16T00:00:00Z